Chlamydia trachomatis secretion of an immunodominant hypothetical protein (CT795) into host cell cytoplasm

Journal of Bacteriology

Volumn 193, Issue 10, 2011, Pages 2498-2509

  Qi, Manli ^a,b   Lei, Lei ^a   Gong, Siqi ^a   Liu, Quanzhong ^b   DeLisa, Matthew P ^c   Zhong, Guangming ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c Cornell University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BACTERIAL PROTEIN; CHLAMYDIA VIRULENCE FACTOR; PROTEIN CT795; SIGNAL PEPTIDASE I; SIGNAL PEPTIDE; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CYTOPLASM; CYTOSOLIC FRACTION; FEMALE; HOST CELL; HUMAN; HUMAN CELL; MOLECULAR RECOGNITION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SECRETION; PROTEIN SYNTHESIS; SEROTYPE;

ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; CHLAMYDIA TRACHOMATIS; CYTOPLASM; ESCHERICHIA COLI; HELA CELLS; HUMANS; VIRULENCE FACTORS;

ANIMALIA; CHLAMYDIA; CHLAMYDIA TRACHOMATIS; ESCHERICHIA COLI;

EID: 79956141341     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.01301-10     Document Type: Article

References (50)

1. Bauwens, J. E., et al. 2002. Epidemic lymphogranuloma venereum during epidemics of crack cocaine use and HIV infection in the Bahamas. Sex. Transm Dis. 29:253-259.
2. Chellas-Gery, B., C. N. Linton, and K. A. Fields. 2007. Human GCIP interacts with CT847, a novel Chlamydia trachomatis type III secretion substrate, and is degraded in a tissue-culture infection model. Cell. Microbiol. 9:2417-2430.
3. Chen, C., et al. 2006. The hypothetical protein CT813 is localized in the Chlamydia trachomatis inclusion membrane and is immunogenic in women urogenitally infected with C. trachomatis. Infect. Immun. 74:4826-4840.
4. Chen, D., J. Chai, P. J. Hart, and G. Zhong. 2009. Identifying catalytic residues in CPAF, a Chlamydia-secreted protease. Arch. Biochem. Biophys. 485:16-23.
5. Chen, D., et al. 2010. Secretion of the chlamydial virulence factor CPAF requires sec-dependent pathway. Microbiology 156:3031-3040.
6. Chen, D., et al. 2010. Characterization of Pgp3, a Chlamydia trachomatis plasmid-encoded immunodominant antigen. J. Bacteriol. 192:6017-6024.
7. Clifton, D. R., et al. 2004. A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. Proc. Natl. Acad. Sci. U. S. A. 101:10166-10171.
8. Cocchiaro, J. L., Y. Kumar, E. R. Fischer, T. Hackstadt, and R. H. Valdivia. 2008. Cytoplasmic lipid droplets are translocated into the lumen of the Chlamydia trachomatis parasitophorous vacuole. Proc. Natl. Acad. Sci. U. S. A. 105:9379-9384.
9. Dong, F., et al. 2006. Localization of the hypothetical protein Cpn0797 in the cytoplasm of Chlamydia pneumoniae-infected host cells. Infect. Immun. 74:6479-6486.
10. Dong, F., M. Pirbhai, Y. Zhong, and G. Zhong. 2004. Cleavage-dependent activation of a chlamydia-secreted protease. Mol. Microbiol. 52:1487-1494.
11. Dong, F., H. Su, Y. Huang, Y. Zhong, and G. Zhong. 2004. Cleavage of host keratin 8 by a Chlamydia-secreted protease. Infect. Immun. 72:3863-3868.
12. Engel, J. 2004. Tarp and Arp: how Chlamydia induces its own entry. Proc. Natl. Acad. Sci. U. S. A. 101:9947-9948.
13. Fan, T., et al. 1998. Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J. Exp. Med. 187:487-496.
14. Fields, K. A., D. J. Mead, C. A. Dooley, and T. Hackstadt. 2003. Chlamydia trachomatis type III secretion: evidence for a functional apparatus during early-cycle development. Mol. Microbiol. 48:671-683.
15. Hackstadt, T., E. R. Fischer, M. A. Scidmore, D. D. Rockey, and R. A. Heinzen. 1997. Origins and functions of the chlamydial inclusion. Trends Microbiol. 5:288-293.
16. Hackstadt, T., M. A. Scidmore, and D. D. Rockey. 1995. Lipid metabolism in Chlamydia trachomatis-infected cells: directed trafficking of Golgi-derived sphingolipids to the chlamydial inclusion. Proc. Natl. Acad. Sci. U. S. A. 92:4877-4881.
17. Hackstadt, T., M. A. Scidmore-Carlson, E. I. Shaw, and E. R. Fischer. 1999. The Chlamydia trachomatis IncA protein is required for homotypic vesicle fusion. Cell. Microbiol. 1:119-130.
18. Hobolt-Pedersen, A. S., G. Christiansen, E. Timmerman, K. Gevaert, and S. Birkelund. 2009. Identification of Chlamydia trachomatis CT621, a protein delivered through the type III secretion system to the host cell cytoplasm and nucleus. FEMS Immunol. Med. Microbiol. 57:46-58.
19. Hower, S., K. Wolf, and K. A. Fields. 2009. Evidence that CT694 is a novel Chlamydia trachomatis T3S substrate capable of functioning during invasion or early cycle development. Mol. Microbiol. 72:1423-1437.
20. Huang, Z., et al. 2008. Structural basis for activation and inhibition of the secreted chlamydia protease CPAF. Cell Host Microbe 4:529-542.
21. Karunakaran, K. P., et al. 2003. Molecular analysis of the multiple GroEL proteins of chlamydiae. J. Bacteriol. 185:1958-1966.
22. Kumar, Y., and R. H. Valdivia. 2008. Actin and intermediate filaments stabilize the Chlamydia trachomatis vacuole by forming dynamic structural scaffolds. Cell Host Microbe 4:159-169.
23. Li, Z., et al. 2008. Characterization of fifty putative inclusion membrane proteins encoded in the Chlamydia trachomatis genome. Infect. Immun. 76:2746-2757.
24. Li, Z., D. Chen, Y. Zhong, S. Wang, and G. Zhong. 2008. The chlamydial plasmid-encoded protein pgp3 is secreted into the cytosol of Chlamydiainfected cells. Infect. Immun. 76:3415-3428.
25. Li, Z., et al. 2008. Antibodies from women urogenitally infected with C. trachomatis predominantly recognized the plasmid protein pgp3 in a conformation-dependent manner. BMC Microbiol. 8:90.
26. Marrichi, M., L. Camacho, D. G. Russell, and M. P. DeLisa. 2008. Genetic toggling of alkaline phosphatase folding reveals signal peptides for all major modes of transport across the inner membrane of bacteria. J. Biol. Chem. 283:35223-35235.
27. McClarty, G. 1994. Chlamydiae and the biochemistry of intracellular parasitism. Trends Microbiol. 2:157-164.
28. Misaghi, S., et al. 2006. Chlamydia trachomatis-derived deubiquitinating enzymes in mammalian cells during infection. Mol. Microbiol. 61:142-150.
29. Peterman, T. A., et al. 2006. High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: a case for rescreening. Ann. Intern. Med. 145:564-572.
30. Pirbhai, M., F. Dong, Y. Zhong, K. Z. Pan, and G. Zhong. 2006. The secreted protease factor CPAF is responsible for degrading pro-apoptotic BH3-only proteins in Chlamydia trachomatis-infected cells. J. Biol. Chem. 281:31495-31501.
31. Rockey, D. D., R. A. Heinzen, and T. Hackstadt. 1995. Cloning and characterization of a Chlamydia psittaci gene coding for a protein localized in the inclusion membrane of infected cells. Mol. Microbiol. 15:617-626.
32. Rockey, D. D., M. A. Scidmore, J. P. Bannantine, and W. J. Brown. 2002. Proteins in the chlamydial inclusion membrane. Microbes Infect. 4:333-340.
33. Scidmore, M. 2008. Chlamydia weave a protective cloak spun of actin and intermediate filaments. Cell Host Microbe 4:93-95.
34. Scidmore, M. A., E. R. Fischer, and T. Hackstadt. 2003. Restricted fusion of Chlamydia trachomatis vesicles with endocytic compartments during the initial stages of infection. Infect. Immun. 71:973-984.
35. Sharma, J., A. M. Bosnic, J. M. Piper, and G. Zhong. 2004. Human antibody responses to a Chlamydia-secreted protease factor. Infect. Immun. 72:7164-7171.
36. Sharma, J., et al. 2006. Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proteins. Infect. Immun. 74:1490-1499.
37. Sherman, K. J., et al. 1990. Sexually transmitted diseases and tubal pregnancy. Sex. Transm. Dis. 17:115-121.
38. Spaargaren, J. 2005. Slow epidemic of lymphogranuloma venereum l2b strain. Emerg. Infect. Dis. 11:1787-1788.
39. Su, H., et al. 2004. Activation of Raf/MEK/ERK/cPLA2 signaling pathway is essential for chlamydial acquisition of host glycerophospholipids. J. Biol. Chem. 279:9409-9416.
40. Subtil, A., et al. 2005. A directed screen for chlamydial proteins secreted by a type III mechanism identifies a translocated protein and numerous other new candidates. Mol. Microbiol. 56:1636-1647.
41. Valdivia, R. H. 2008. Chlamydia effector proteins and new insights into chlamydial cellular microbiology. Curr. Opin. Microbiol. 11:53-59.
42. Vandahl, B. B., A. Stensballe, P. Roepstorff, G. Christiansen, and S. Birkelund. 2005. Secretion of Cpn0796 from Chlamydia pneumoniae into the host cell cytoplasm by an autotransporter mechanism. Cell. Microbiol. 7:825-836.
43. Wang, J., et al. 2010. A genome-wide profiling of the humoral immune response to Chlamydia trachomatis infection reveals vaccine candidate antigens expressed in humans. J. Immunol. 185:1670-1680.
44. Wolf, K., et al. 2006. Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle. Mol. Microbiol. 61:1543-1555.
45. Wright, H. R., A. Turner, and H. R. Taylor. 2008. Trachoma. Lancet 371: 1945-1954.
46. Zhong, G. 2009. Killing me softly: chlamydial use of proteolysis for evading host defenses. Trends Microbiol. 17:467-474.
47. Zhong, G., P. Fan, H. Ji, F. Dong, and Y. Huang. 2001. Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J. Exp. Med. 193:935-942.
48. Zhong, G., T. Fan, and L. Liu. 1999. Chlamydia inhibits interferon gammainducible major histocompatibility complex class II expression by degradation of upstream stimulatory factor 1. J. Exp. Med. 189:1931-1938.
49. Zhong, G., L. Liu, T. Fan, P. Fan, and H. Ji. 2000. Degradation of transcription factor RFX5 during the inhibition of both constitutive and interferon gamma-inducible major histocompatibility complex class I expression in chlamydia-infected cells. J. Exp. Med. 191:1525-1534.
50. Zhong, G., C. Reis e Sousa, and R. N. Germain. 1997. Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein. Proc. Natl. Acad. Sci. U. S. A. 94:13856-13861.